Aperio

Pathology goes digital.

Worldwide leader Aperio has an award-winning, patented system that delivers digital slide creation, viewing, management, and analysis capabilities to the pathologist's fingertips. Aperio removes the constraints that tether pathologists to microscopes and glass slides, and opens a whole new world of remote medicine, anywhere/anytime access, and automated analysis. This removal of dependence on physical glass slides represents a revolutionary leap forward; pathology now stands ready to realize the same productivity benefits radiology has enjoyed for years.

Protection of Aperio's leading technology required Procopio's specialized patent expertise and helped Aperio secure $17 million in Series B funding. The round will drive new innovation and world wide market expansion. The pathway was opened for funding after Procopio's intellectual property litigators successfully secured a favorable settlement of patent litigation by a competitor attempting to impede Aperio's exponential growth.

Procopio's innovative legal strategy is helping realize Aperio's revolutionary vision.

Next Testimonial » « Previous Testimonial